Breaking News

Thursday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
On The Fly
Biotech Alert: Searches spiking for these stocks today » 11:18
04/18/24
04/18
11:18
04/18/24
11:18
ITCI

Intra-Cellular

$73.15 /

-3.52 (-4.59%)

, SNGX

Soligenix

/

+

, MRNS

Marinus Pharmaceuticals

$1.47 /

+0.03 (+2.08%)

, BHVN

Biohaven

$41.68 /

-2.37 (-5.38%)

, JAGX

Jaguar Health

/

+

, NCNA

NuCana

$4.05 /

-0.1 (-2.41%)

, CRBP

Corbus Pharmaceuticals

$37.26 /

-0.095 (-0.25%)

, NTLA

Intellia Therapeutics

$21.80 /

+0.29 (+1.35%)

These names in the…

Over a month ago
Hot Stocks
Intellia Therapeutics announces first patient dosed in Phase 3 MAGNITUDE study » 07:38
03/18/24
03/18
07:38
03/18/24
07:38
NTLA

Intellia Therapeutics

$28.30 /

+0.8 (+2.91%)

Intellia Therapeutics…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Downgrade
Intellia Therapeutics just downgraded at Goldman Sachs, here's why » 09:18
02/23/24
02/23
09:18
02/23/24
09:18
NTLA

Intellia Therapeutics

$27.17 /

+0.33 (+1.23%)

Goldman Sachs analyst…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Recommendations
Intellia Therapeutics price target lowered by $14 at Guggenheim, here's why » 08:47
02/23/24
02/23
08:47
02/23/24
08:47
NTLA

Intellia Therapeutics

$27.17 /

+0.33 (+1.23%)

Guggenheim analyst Debjit…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Recommendations
Intellia Therapeutics price target raised by $1 at Canaccord, here's why » 07:22
02/23/24
02/23
07:22
02/23/24
07:22
NTLA

Intellia Therapeutics

$27.17 /

+0.33 (+1.23%)

Canaccord raised the…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Earnings
Intellia Therapeutics reports Q4 EPS ($1.46), consensus ($1.45) » 07:35
02/22/24
02/22
07:35
02/22/24
07:35
NTLA

Intellia Therapeutics

$26.84 /

-0.34 (-1.25%)

"We're off to a…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Recommendations
Intellia Therapeutics price target lowered by $14 at Baird, here's why » 07:14
02/16/24
02/16
07:14
02/16/24
07:14
NTLA

Intellia Therapeutics

$28.44 /

+0.16 (+0.57%)

, ALNY

Alnylam

$147.48 /

-16.66 (-10.15%)

Baird lowered the…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Hot Stocks
Intellia Therapeutics, ReCode Therapeutics to develop genomic medicines for CF » 07:43
02/15/24
02/15
07:43
02/15/24
07:43
NTLA

Intellia Therapeutics

$28.28 /

+1.825 (+6.90%)

Intellia Therapeutics and…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Hot Stocks
Intellia Therapeutics, ReCode Therapeutics announce collaboration » 07:36
02/15/24
02/15
07:36
02/15/24
07:36
NTLA

Intellia Therapeutics

$28.28 /

+1.825 (+6.90%)

Intellia Therapeutics…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Initiation
Intellia Therapeutics initiated with neutral view at Wolfe Research, here's why » 19:23
02/14/24
02/14
19:23
02/14/24
19:23
NTLA

Intellia Therapeutics

$28.28 /

+1.825 (+6.90%)

Wolfe Research initiated…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Initiation
Intellia Therapeutics initiated with neutral view at Wolfe Research » 16:16
02/14/24
02/14
16:16
02/14/24
16:16
NTLA

Intellia Therapeutics

$28.28 /

+1.825 (+6.90%)

Wolfe Research initiated…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Hot Stocks
Cathie Wood's ARK Investment bought 131K shares of Intellia Therapeutics today 20:04
02/05/24
02/05
20:04
02/05/24
20:04
NTLA

Intellia Therapeutics

$24.83 /

-0.45 (-1.78%)

 
Hot Stocks
Intellia Therapeutics announces publication of NTLA-2002 data in NEJM » 17:02
01/31/24
01/31
17:02
01/31/24
17:02
NTLA

Intellia Therapeutics

$23.81 /

-0.78 (-3.17%)

Intellia Therapeutics…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Conference/Events
Cantor Fitzgerald biotech analysts hold an analyst/industry conference call » 13:15
01/30/24
01/30
13:15
01/30/24
13:15
MREO

Mereo BioPharma

$3.84 /

-0.215 (-5.30%)

, ARWR

Arrowhead

$33.23 /

-1.195 (-3.47%)

, BEAM

Beam Therapeutics

$26.00 /

-2.3 (-8.13%)

, NTLA

Intellia Therapeutics

$24.83 /

-1.35 (-5.16%)

, VRTX

Vertex Pharmaceuticals

$443.94 /

+8.01 (+1.84%)

Biotech Analysts Kluska…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Conference/Events
Cantor Fitzgerald biotech analysts hold an analyst/industry conference call » 10:55
01/30/24
01/30
10:55
01/30/24
10:55
MREO

Mereo BioPharma

$3.98 /

-0.08 (-1.97%)

, ARWR

Arrowhead

$33.40 /

-1.025 (-2.98%)

, BEAM

Beam Therapeutics

$26.39 /

-1.91 (-6.75%)

, NTLA

Intellia Therapeutics

$25.34 /

-0.84 (-3.21%)

, VRTX

Vertex Pharmaceuticals

$435.12 /

-0.81 (-0.19%)

Biotech Analysts Kluska…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Over a quarter ago
Recommendations
Intellia Therapeutics price target lowered by $13 at Stifel, here's why » 09:55
01/08/24
01/08
09:55
01/08/24
09:55
NTLA

Intellia Therapeutics

$28.16 /

-0.485 (-1.69%)

Stifel lowered the…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
On The Fly
The Smid-cap biotech stocks to own in 2024, according to Bernstein » 11:19
01/02/24
01/02
11:19
01/02/24
11:19
VRTX

Vertex Pharmaceuticals

$410.12 /

+2.95 (+0.72%)

, ALNY

Alnylam

$193.13 /

+1.645 (+0.86%)

, NTLA

Intellia Therapeutics

$31.64 /

+1.17 (+3.84%)

, BMRN

BioMarin

$97.97 /

+1.565 (+1.62%)

, BEAM

Beam Therapeutics

$28.03 /

+0.84 (+3.09%)

, ARWR

Arrowhead

$31.37 /

+0.76 (+2.48%)

, ALLO

Allogene Therapeutics

$3.53 /

+0.33 (+10.31%)

, IONS

Ionis Pharmaceuticals

$53.49 /

+2.91 (+5.75%)

Discussing the biotech…

Recommendations
Crispr Therapeutics price target raised to $57 from $50 at RBC Capital » 08:24
12/11/23
12/11
08:24
12/11/23
08:24
CRSP

Crispr Therapeutics

$64.50 /

-5.69 (-8.11%)

, VRTX

Vertex Pharmaceuticals

$349.91 /

-4.01 (-1.13%)

, BLUE

Bluebird Bio

$2.86 /

-1.945 (-40.52%)

, NTLA

Intellia Therapeutics

$29.02 /

-0.75 (-2.52%)

RBC Capital analyst Luca…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Syndicate
Intellia Therapeutics files automatic mixed securities shelf 09:38
11/24/23
11/24
09:38
11/24/23
09:38
NTLA

Intellia Therapeutics

$30.26 /

+1.785 (+6.27%)

 
Hot Stocks
Intellia Therapeutics receives European Union ODD for NTLA-2002 » 07:46
11/14/23
11/14
07:46
11/14/23
07:46
NTLA

Intellia Therapeutics

$23.82 /

-0.32 (-1.33%)

Intellia Therapeutics…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Recommendations
Intellia Therapeutics price target lowered to $70 from $80 at Oppenheimer » 06:18
11/13/23
11/13
06:18
11/13/23
06:18
NTLA

Intellia Therapeutics

$24.14 /

-0.81 (-3.25%)

Oppenheimer lowered the…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Recommendations
Intellia Therapeutics price target lowered to $95 from $100 at Wells Fargo » 07:50
11/10/23
11/10
07:50
11/10/23
07:50
NTLA

Intellia Therapeutics

$24.96 /

-3.47 (-12.21%)

Wells Fargo analyst Yanan…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Recommendations
Intellia Therapeutics price target raised to $72 from $65 at Canaccord » 07:33
11/10/23
11/10
07:33
11/10/23
07:33
NTLA

Intellia Therapeutics

$24.96 /

-3.47 (-12.21%)

Canaccord analyst Whitney…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Recommendations
Intellia Therapeutics price target lowered to $31 from $40 at Citi » 06:21
11/10/23
11/10
06:21
11/10/23
06:21
NTLA

Intellia Therapeutics

$24.96 /

-3.47 (-12.21%)

Citi analyst David…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Recommendations
Intellia Therapeutics price target lowered to $76 from $90 at Barclays » 05:44
11/10/23
11/10
05:44
11/10/23
05:44
NTLA

Intellia Therapeutics

$24.96 /

-3.47 (-12.21%)

Barclays analyst Gena…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Earnings
Intellia Therapeutics reports Q3 EPS ($1.38), consensus ($1.50) » 07:36
11/09/23
11/09
07:36
11/09/23
07:36
NTLA

Intellia Therapeutics

$28.43 /

-1.07 (-3.63%)

Reports Q3 revenue…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Hot Stocks
Intellia Therapeutics announces new interim data on NTLA-2001 » 07:24
11/02/23
11/02
07:24
11/02/23
07:24
NTLA

Intellia Therapeutics

$25.49 /

+0.43 (+1.72%)

Intellia Therapeutics…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account
Hot Stocks
Cathie Wood's ARK Investment bought 284K shares of Intellia Therapeutics today 20:40
10/19/23
10/19
20:40
10/19/23
20:40
NTLA

Intellia Therapeutics

$27.12 /

-0.82 (-2.93%)

 
Hot Stocks
Cathie Wood's ARK Investment bought 241K shares of Intellia Therapeutics today 20:04
10/18/23
10/18
20:04
10/18/23
20:04
NTLA

Intellia Therapeutics

$27.96 /

-1.07 (-3.69%)

 
Hot Stocks
Intellia Therapeutics announces FDA clearance of IND for NTLA-2001 Phase 3 trial » 07:04
10/18/23
10/18
07:04
10/18/23
07:04
NTLA

Intellia Therapeutics

$29.03 /

-0.67 (-2.26%)

Intellia Therapeutics…
Available to The Fly Members Only
Breaking content available to members only. Sign up or login for access.
Create FREE Account

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.